samedan logo
 
 
spacer
home > epc > Summer 2014
PUBLICATIONS

European Pharmaceutical Contractor

epc
Summer 2014

   
Text
PDF
bullet
Marketplace & Business
CRO Marketplace

Value Added

Adam M Dion
at GlobalData suggests that accomodating a diverse range of clients is the best solution to challenges facing contract research organisations - companies are now offering new services to increase revenue and appeal to firms which are set to lead future innovation.

 
view
download pdf
Process Management Systems

Business Growth


Improving process management is always worthwhile, whatever a company’s goals. Richard Holland at TBM Consulting says renewing your system could be the key to greater efficiency, long-term reliability and continuous productivity.
 
view
download pdf
bullet
Legal & Regulatory
Clinical Trial Regulation

All Change


Recent updates to EU clinical trial regulation will impact many areas of drug development, says ICON's Daphne Smyth. Among the benefits of the changes are quicker access to treatments and streamlined legislation across member states.

 
view
download pdf
Drug Approval

The Right Path


With the ever-present need for greater efficiency and lower costs, Ken Phelps at Camargo Pharmaceutical Services explains why some companies are turning to the 505(b)(2) pathway, which opens up a quicker, less expensive drug development route.

 
view
download pdf
Intellectual Property

Added Protection


A good understanding of intellectual property protection can deliver increased revenue and the ability to tap into market niches. However, applying initiatives is a complex task, argue Victor Caddy and Lyndsey Lynch at Wynne-Jones IP.

 
view
download pdf
Outsourcing Regulatory Affairs

Safe Strategy

MakroCare’s Mahesh Malneedi
describes the best strategy to implement when choosing to outsource regulatory affairs. He recommends devising a risk-averse plan and selecting a firm with varied offerings.
 
view
download pdf
EU Pharmacovigilance

A New Mindset


The full impact of the pharmacovigilance updates of 2012 is yet to be seen, believes Doris Stenver at the Danish Health and Medicines Authority. She suggests that the revisions will eventually lead to a whole new way of thinking.
 
view
download pdf
bullet
Therapeutic Innovation
Vaccine Formulations

New Potential


The new development of solid state circular dichroism goes beyond traditional vaccine analysis. Allan Watkinson and Jan Vos of XstalBio explain how this technique can offer a deeper understanding of formulations.
 
view
download pdf
bullet
DATA MANAGEMENT
Serialisation Programs

Bigger Data


Ramesh J Chougule of Infosys explains how implementing a new serialisation program – and moving away from traditional data tracking methods – can translate into improved efficiency, precision and cost-saving.
 
view
download pdf
bullet
STAFF RECRUITMENT & TRAINING
Competence Verification

Standard of Care

Martin Robinson
at the International Academy of Clinical Research outlines the findings from a recent report highlighting the need to readdress patient requirements and increase the public's protection. He reasons that competence verification could remedy the issues.


 
view
download pdf
bullet
Clinical Laboratories
Microbiological Testing

The Central Issue


Deciding on the most suitable type of laboratory for the microbiological stage of a clinical trial can be problematic. PSI CRO's Andrey Karelin, Maxim Belotserkovsky, Veronika Khokhlova and Olga Sazonova outline the various considerations

 
view
download pdf
bullet
Cool Chain, Labs & Logistics
Cold Chain

Evolving Markets


Stephen Healy at Intelsius demonstrates why emerging markets possess the greatest opportunity for market growth, and how they could contribute to a supply chain evolution.
 
view
download pdf

Interview
Industry Interview

Better, Faster, Stronger


Helping customers accelerate research progress is the most rewarding part of Jim Carroll’s role at iCTRS. Here, he tells EPC how to get ahead when reducing patient enrolment timelines.
 
view
download pdf
Industry Interview

Data Driven


Elizabeth Brooks at Decision Driver Analytics speaks to EPC on why business decisions should be approached with a rigourous and practical view, while being driven by analytics.
 
view
download pdf
   
spacer



Published quarterly in
February, May,
August, and November

News and Press Releases

CHDI Foundation extends collaboration with IRBM to accelerate development of Huntington’s disease therapeutics

IRBM, a global contract research organization (CRO), has strengthened its position in neurodegenerative disease research following an extension of its long-standing collaboration with CHDI Foundation, a nonprofit biomedical research organization exclusively dedicated to collaboratively developing therapeutics that substantially improve the lives of those affected by Huntington’s disease (HD).
More info >>

White Papers

Detecting Integrity Breaches in a range of Pharmaceutical Blister Package Types using Sepha VisionScan

Sepha Limited

Demonstrating the integrity of pharmaceutical blister packs is critically important, as any defects can affect the shelf life and efficacy of the contents. Compared to bulk packaging, blister packs offer improved product integrity, tamper evidence and reduce the likelihood of misuse. Packs can be composed of either a thermoformed polymer or cold formed aluminium tray, with a number of individual pockets to hold the product. After the tablets or capsules are placed in the pockets, the packs are heat sealed with a paper or foil laminate sheet. These various stages can be completed separately or integrated into a single form, fill and seal process. There is a risk of microbial containment or degradation of the contents if any defects are present in the packaging. Such defects can take the form of rips or pinholes in the tray, or lid materials, faulty seals and channel leaks between pockets.
More info >>

Industry Events

CPhI & P-MEC India 2018

12-14 December 2018, India Expo Mart, New Delhi, India

CPhI & P-MEC India (December 12-14, 2018) – organised by UBM (part of Informa PLC) – announces that the 12th edition of Asia’s largest Pharma exhibition is moving to the India Expo Mart, New Delhi. The new venue will see the exhibition now hosted in a single venue, bringing it closer to the Indian regulatory and legislative capital. New Delhi is also the country’s main international transport hub and will encourage an increased international attendance. In total, more than 50,000 people from 122 countries are expected, along with nearly 1,500 exhibitors.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement